百诚医药
(301096)
| 流通市值：47.60亿 | | | 总市值：75.00亿 |
| 流通股本：6912.19万 | | | 总股本：1.09亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 790,555,445.57 | 881,929,187.54 | 921,138,712.99 | 1,079,047,020.29 |
| 应收票据及应收账款 | 252,875,164.08 | 213,203,221.46 | 204,551,989.49 | 201,793,537.66 |
| 其中：应收票据 | 4,457,917 | 13,283,651.38 | 10,298,876.38 | 5,030,777.18 |
| 应收账款 | 248,417,247.08 | 199,919,570.08 | 194,253,113.11 | 196,762,760.48 |
| 预付款项 | 53,517,735.32 | 42,284,124.98 | 50,426,370.67 | 36,472,233.94 |
| 其他应收款合计 | 3,160,017.64 | 4,097,997.87 | 5,404,536.36 | 4,570,525.81 |
| 存货 | 123,746,092.38 | 93,173,602.59 | 87,657,982.84 | 90,854,372.72 |
| 合同资产 | 369,736,213.16 | 318,976,691.13 | 246,039,873.68 | 220,300,382.17 |
| 其他流动资产 | 75,981,291.87 | 54,119,099.46 | 43,495,045.1 | 37,658,361.34 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,669,571,960.02 | 1,607,783,925.03 | 1,558,714,511.13 | 1,670,696,433.93 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | 1,969,571.64 | 1,951,878.49 |
| 长期股权投资 | 16,523,250.61 | 16,362,054.68 | - | - |
| 其他非流动金融资产 | 125,506,267.6 | 120,506,267.6 | 129,686,267.6 | 113,780,267.6 |
| 固定资产 | 1,656,551,353.14 | 1,290,616,675.28 | 1,199,035,618.51 | 1,026,928,503.91 |
| 在建工程 | 164,316,956.51 | 448,816,461.27 | 291,041,807.99 | 329,740,172.56 |
| 使用权资产 | 1,050,264.41 | 1,137,902.66 | 68,553.96 | 109,686.27 |
| 无形资产 | 92,783,509.89 | 92,070,166.52 | 80,386,408.24 | 81,018,813.41 |
| 长期待摊费用 | 176,553.85 | 246,589.96 | 619,576.37 | 395,854.32 |
| 递延所得税资产 | 52,430,560.22 | 48,426,196.55 | 65,243,386.32 | 73,197,856.86 |
| 其他非流动资产 | 55,780,268.6 | 43,139,897.56 | 79,333,642.33 | 83,703,594.04 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,165,118,984.83 | 2,061,322,212.08 | 1,847,384,832.96 | 1,710,826,627.46 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,834,690,944.85 | 3,669,106,137.11 | 3,406,099,344.09 | 3,381,523,061.39 |
| 流动负债: | | | | |
| 短期借款 | 634,023,813.91 | 369,319,550.02 | 290,217,777.78 | 280,209,722.22 |
| 应付票据及应付账款 | 233,871,157.79 | 323,381,376.21 | 239,701,549.41 | 221,003,017.17 |
| 其中：应付票据 | 100,355,197.05 | 103,418,472.6 | 91,449,392.6 | 62,221,390 |
| 应付账款 | 133,515,960.74 | 219,962,903.61 | 148,252,156.81 | 158,781,627.17 |
| 合同负债 | 64,014,704.69 | 74,012,974.58 | 90,553,136.97 | 79,424,895.65 |
| 应付职工薪酬 | 22,041,317.01 | 64,507,072.83 | 32,468,068.65 | 24,973,351.07 |
| 应交税费 | 7,855,318.7 | 12,087,325.1 | 27,751,895.24 | 22,580,262.47 |
| 其他应付款合计 | 1,216,701.86 | 2,497,721.29 | 1,686,260.36 | 1,457,436.74 |
| 一年内到期的非流动负债 | 395,110.7 | 384,687.92 | 177,834.2 | 177,834.2 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 963,418,124.66 | 846,190,707.95 | 682,556,522.61 | 629,826,519.52 |
| 非流动负债: | | | | |
| 租赁负债 | 913,491.58 | 933,051.39 | - | - |
| 预计负债 | 89,466,375.86 | 97,170,480.29 | 78,332,449.94 | 201,531,101.83 |
| 递延收益 | 39,504,430.08 | 40,674,766.36 | 40,973,327.64 | 1,372,555.59 |
| 递延所得税负债 | - | - | 3,959,377.33 | 4,100,329.69 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 129,884,297.52 | 138,778,298.04 | 123,265,154.91 | 207,003,987.11 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,093,302,422.18 | 984,969,005.99 | 805,821,677.52 | 836,830,506.63 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,919,903 | 108,919,903 | 108,166,667 | 108,166,667 |
| 资本公积 | 2,134,110,960.5 | 2,126,676,428.24 | 2,098,027,963.62 | 2,090,417,199.85 |
| 减:库存股 | 49,998,224.77 | 49,998,224.77 | 34,050,370.53 | - |
| 其他综合收益 | -137,536.8 | -136,186.95 | -63,253.26 | -61,142.5 |
| 盈余公积 | 54,459,951.5 | 54,459,951.5 | 42,777,305.34 | 42,777,305.34 |
| 未分配利润 | 494,033,469.24 | 444,215,260.1 | 385,419,354.4 | 303,392,525.07 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,741,388,522.67 | 2,684,137,131.12 | 2,600,277,666.57 | 2,544,692,554.76 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,741,388,522.67 | 2,684,137,131.12 | 2,600,277,666.57 | 2,544,692,554.76 |
| 负债和股东权益合计 | 3,834,690,944.85 | 3,669,106,137.11 | 3,406,099,344.09 | 3,381,523,061.39 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-26 | 2023-08-10 |
| 审计意见(境内) | | 标准无保留意见 | | |